BCTX
Briacell Therapeutics
BCTX
BCTX
17 hedge funds and large institutions have $19.4M invested in Briacell Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
3
Closed
5
Calls
$7.55M
Puts
–
Net Calls
+$7.55M
Net Calls Change
+$4.47M
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.56M |
| 2 |
Morgan Stanley
New York
|
+$498K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$228K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$109K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$107K |
Top Sellers
| 1 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$2.39M |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$186K |
| 3 |
VF
Virtu Financial
New York
|
-$89K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$60.2K |
| 5 |
N
Natixis
Paris,
France
|
-$56.3K |
